Potential Pharmacological Target of Tight Junctions to improve the BBB Permeability in Neonatal Hypoxic-Ischemic Encephalopathy Diseases.
暂无分享,去创建一个
[1] Kazuki Hatayama,et al. Time Course of Changes in the Neurovascular Unit after Hypoxic-Ischemic Injury in Neonatal Rats , 2022, International journal of molecular sciences.
[2] Junichi Ikenouchi,et al. Tricellulin secures the epithelial barrier at tricellular junctions by interacting with actomyosin , 2022, The Journal of cell biology.
[3] R. Hamoudi,et al. miR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability , 2022, PloS one.
[4] R. Zorec,et al. Lactate as an Astroglial Signal Augmenting Aerobic Glycolysis and Lipid Metabolism , 2021, Frontiers in Physiology.
[5] Monica Giannotta,et al. The blood–brain and gut–vascular barriers: from the perspective of claudins , 2021, Tissue barriers.
[6] Xiaomin Zhu,et al. Targeting microRNAs to Regulate the Integrity of the Blood–Brain Barrier , 2021, Frontiers in Bioengineering and Biotechnology.
[7] J. Brewer,et al. Junctional adhesion molecule-A on dendritic cells regulates Th1 differentiation. , 2021, Immunology letters.
[8] B. Engelhardt,et al. Brain endothelial tricellular junctions as novel sites for T cell diapedesis across the blood–brain barrier , 2021, Journal of cell science.
[9] K. Jandová,et al. Perinatal hypoxic-ischemic damage: review of the current treatment possibilities. , 2021, Physiological research.
[10] Jean X. Jiang,et al. Connexin Gap Junctions and Hemichannels Link Oxidative Stress to Skeletal Physiology and Pathology , 2021, Current Osteoporosis Reports.
[11] Michael Koval. Connexins , 2021, Reference Module in Biomedical Sciences.
[12] Kyoko Furuse,et al. Angulin-1 seals tricellular contacts independently of tricellulin and claudins , 2020, bioRxiv.
[13] K. Liu,et al. Occludin regulation of blood–brain barrier and potential therapeutic target in ischemic stroke , 2020, Brain circulation.
[14] G. Holman. Structure, function and regulation of mammalian glucose transporters of the SLC2 family , 2020, Pflügers Archiv - European Journal of Physiology.
[15] W. Hunziker,et al. The Mammalian Crumbs Complex Defines a Distinct Polarity Domain Apical of Epithelial Tight Junctions , 2020, Current Biology.
[16] M. Campbell,et al. Tight junction modulation at the blood-brain barrier: Current and future perspectives. , 2020, Biochimica et biophysica acta. Biomembranes.
[17] K. Yin,et al. Endothelium-targeted deletion of the miR-15a/16-1 cluster ameliorates blood-brain barrier dysfunction in ischemic stroke , 2020, Science Signaling.
[18] K. Houkin,et al. FTY720 Protects Against Ischemia–Reperfusion Injury by Preventing the Redistribution of Tight Junction Proteins and Decreases Inflammation in the Subacute Phase in an Experimental Stroke Model , 2020, Translational Stroke Research.
[19] D. Oorschot,et al. Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research , 2020, International journal of molecular sciences.
[20] Clémence Disdier,et al. Hypoxic-ischemic related cerebrovascular changes and potential therapeutic strategies in the neonatal brain , 2019, Journal of neuroscience research.
[21] L. Kozák,et al. Neurodevelopmental effect of intracranial hemorrhage observed in hypoxic ischemic brain injury in hypothermia-treated asphyxiated neonates - an MRI study , 2019, BMC Pediatrics.
[22] B. Engelhardt,et al. Structure and Junctional Complexes of Endothelial, Epithelial and Glial Brain Barriers , 2019, International journal of molecular sciences.
[23] S. Ayloo,et al. Development and Cell Biology of the Blood-Brain Barrier. , 2019, Annual review of cell and developmental biology.
[24] P. Zheng,et al. Neuroprotective effect of Vanillin on hypoxic-ischemic brain damage in neonatal rats. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[25] K. Ebnet,et al. Claudins and JAM-A coordinately regulate tight junction formation and epithelial polarity , 2019, The Journal of cell biology.
[26] M. Lauritzen,et al. Apolipoprotein M-bound sphingosine-1-phosphate regulates blood–brain barrier paracellular permeability and transcytosis , 2019, bioRxiv.
[27] F. Silverstein,et al. Repurposing Azithromycin for Neonatal Neuroprotection , 2019, Pediatric Research.
[28] A. Gunn,et al. The Role of Connexin and Pannexin Channels in Perinatal Brain Injury and Inflammation , 2019, Front. Physiol..
[29] S. T. Bjorkman,et al. Seizures Are Associated with Blood-Brain Barrier Disruption in a Piglet Model of Neonatal Hypoxic-Ischaemic Encephalopathy , 2019, Developmental Neuroscience.
[30] A. Gunn,et al. A working model for hypothermic neuroprotection , 2018, The Journal of physiology.
[31] C. Dani,et al. Changes in bilirubin in infants with hypoxic–ischemic encephalopathy , 2018, European Journal of Pediatrics.
[32] W. Nelson,et al. Cell-Cell Junctions Organize Structural and Signaling Networks. , 2018, Cold Spring Harbor perspectives in biology.
[33] K. Ebnet,et al. Junctional Adhesion Molecules (JAMs): The JAM-Integrin Connection , 2018, Cells.
[34] J. Hervé. Membrane channels formed by gap junction proteins. , 2018, Biochimica et biophysica acta. Biomembranes.
[35] Farhad Farjood,et al. Physical disruption of cell–cell contact induces VEGF expression in RPE cells , 2017, Molecular vision.
[36] Ann L. Miller,et al. Tricellular junctions: how to build junctions at the TRICkiest points of epithelial cells , 2017, Molecular biology of the cell.
[37] Lubo Zhang,et al. MicroRNA-210 Suppresses Junction Proteins and Disrupts Blood-Brain Barrier Integrity in Neonatal Rat Hypoxic-Ischemic Brain Injury , 2017, International journal of molecular sciences.
[38] D. Shah,et al. Hypoxic-Ischaemic Encephalopathy and the Blood-Brain Barrier in Neonates , 2017, Developmental Neuroscience.
[39] Á. Simonyi,et al. TNFα alters occludin and cerebral endothelial permeability: Role of p38MAPK , 2017, PloS one.
[40] V. A. Ruzaeva,et al. Tight junction proteins of cerebral endothelial cells in early postnatal development , 2016, Cell and Tissue Biology.
[41] A. Panigrahy,et al. The effects of therapeutic hypothermia on cerebral metabolism in neonates with hypoxic-ischemic encephalopathy: An in vivo 1H-MR spectroscopy study , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[42] M. Falk,et al. Molecular mechanisms regulating formation, trafficking and processing of annular gap junctions , 2016, BMC Cell Biology.
[43] Huchuan Zhou,et al. Hyperbaric oxygen preconditioning ameliorates blood-brain barrier damage induced by hypoxia through modulation of tight junction proteins in an in vitro model , 2016, Croatian medical journal.
[44] W. Banks,et al. From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery , 2016, Nature Reviews Drug Discovery.
[45] C. Tassorelli,et al. Azithromycin protects mice against ischemic stroke injury by promoting macrophage transition towards M2 phenotype , 2016, Experimental Neurology.
[46] Chenghua Gu,et al. The Molecular Constituents of the Blood–Brain Barrier , 2015, Trends in Neurosciences.
[47] John H. Zhang,et al. G-CSF attenuates neuroinflammation and stabilizes the blood–brain barrier via the PI3K/Akt/GSK-3β signaling pathway following neonatal hypoxia-ischemia in rats , 2015, Experimental Neurology.
[48] X. Ji,et al. Intra-artery infusion of recombinant human erythropoietin reduces blood–brain barrier disruption in rats following cerebral ischemia and reperfusion , 2015, The International journal of neuroscience.
[49] Michael D Weiss,et al. Hypoxic-ischemic encephalopathy: a review for the clinician. , 2015, JAMA pediatrics.
[50] P. Eunson. The long‐term health, social, and financial burden of hypoxic–ischaemic encephalopathy , 2015, Developmental medicine and child neurology.
[51] J. Boardman,et al. Hypoglycaemia and hypoxic–ischaemic encephalopathy , 2015, Developmental medicine and child neurology.
[52] Christina Lin,et al. LSR/angulin-1 is a tricellular tight junction protein involved in blood–brain barrier formation , 2015, The Journal of cell biology.
[53] M. Chopp,et al. Deficiency of Brain ATP-Binding Cassette Transporter A-1 Exacerbates Blood–Brain Barrier and White Matter Damage After Stroke , 2015, Stroke.
[54] H. Hagberg,et al. Brain barrier properties and cerebral blood flow in neonatal mice exposed to cerebral hypoxia-ischemia , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[55] L. Zhang,et al. Vascular endothelial growth factor increases GEnC permeability by affecting the distributions of occludin, ZO-1 and tight juction assembly. , 2015, European review for medical and pharmacological sciences.
[56] A. Traweger,et al. “You Shall Not Pass”—tight junctions of the blood brain barrier , 2014, Front. Neurosci..
[57] M. Furuse,et al. Tricellulin regulates junctional tension of epithelial cells at tricellular contacts through Cdc42 , 2014, Journal of Cell Science.
[58] Yi-Sook Jung,et al. Hypoxia induces FoxO3a-mediated dysfunction of blood-brain barrier. , 2014, Biochemical and biophysical research communications.
[59] T. Stehle,et al. Trans-dimerization of JAM-A regulates Rap2 and is mediated by a domain that is distinct from the cis-dimerization interface , 2014, Molecular biology of the cell.
[60] S. Strickland,et al. Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity , 2014, Nature Communications.
[61] O. Ogunshola,et al. Cell‐specific blood–brain barrier regulation in health and disease: a focus on hypoxia , 2014, British journal of pharmacology.
[62] H. Wolburg,et al. Highly conserved cysteines are involved in the oligomerization of occludin-redox dependency of the second extracellular loop. , 2014, Antioxidants & redox signaling.
[63] A. Frampton,et al. Gene of the month: E-cadherin (CDH1) , 2013, Journal of Clinical Pathology.
[64] L. McCullough,et al. Inflammatory responses in hypoxic ischemic encephalopathy , 2013, Acta Pharmacologica Sinica.
[65] S. Krol,et al. Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier. , 2013, Chemical reviews.
[66] H. Wolburg,et al. In tight junctions, claudins regulate the interactions between occludin, tricellulin and marvelD3, which, inversely, modulate claudin oligomerization , 2013, Journal of Cell Science.
[67] O. Makeyev,et al. Ischemia–reperfusion impairs blood–brain barrier function and alters tight junction protein expression in the ovine fetus , 2012, Neuroscience.
[68] D. Walker,et al. Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair? , 2012, Front. Physio..
[69] Beth L. Pruitt,et al. E-cadherin is under constitutive actomyosin-generated tension that is increased at cell–cell contacts upon externally applied stretch , 2012, Proceedings of the National Academy of Sciences.
[70] M. Wendland,et al. Blood–Brain Barrier Permeability Is Increased After Acute Adult Stroke But Not Neonatal Stroke in the Rat , 2012, The Journal of Neuroscience.
[71] J. Gidday,et al. Junctional Protein Regulation by Sphingosine Kinase 2 Contributes to Blood–Brain Barrier Protection in Hypoxic Preconditioning-Induced Cerebral Ischemic Tolerance , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[72] A. Gunn,et al. Deleterious Effects of High Dose Connexin 43 Mimetic Peptide Infusion After Cerebral Ischaemia in Near-Term Fetal Sheep , 2012, International journal of molecular sciences.
[73] P. Cummins. Occludin: One Protein, Many Forms , 2011, Molecular and Cellular Biology.
[74] T. Endo,et al. Predicted expansion of the claudin multigene family , 2011, FEBS letters.
[75] W. Pardridge. The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.
[76] B. Barres,et al. Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.
[77] C. V. Van Itallie,et al. Occludin is required for cytokine-induced regulation of tight junction barriers , 2010, Journal of Cell Science.
[78] Nadia Badawi,et al. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. , 2010, Early human development.
[79] S. Tsukita,et al. Loss of occludin affects tricellular localization of tricellulin. , 2008, Molecular biology of the cell.
[80] Sriparna Basu,et al. Free Radical Injury and Blood-Brain Barrier Permeability in Hypoxic-Ischemic Encephalopathy , 2008, Pediatrics.
[81] J. Piontek,et al. Structure and function of claudins. , 2008, Biochimica et biophysica acta.
[82] K. Preissner,et al. Flt‐1, but not Flk‐1 mediates hyperpermeability through activation of the PI3‐K/Akt pathway , 2007, Journal of cellular physiology.
[83] Li Zhang,et al. Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes. , 2006, Physiological genomics.
[84] E. Hansson,et al. Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.
[85] S. Tsukita,et al. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells , 2005, The Journal of cell biology.
[86] D. Ferriero. Neonatal brain injury. , 2004, The New England journal of medicine.
[87] S. Tsukita,et al. Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.
[88] W. Schaper,et al. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. , 2002, Microvascular research.
[89] N. Jones,et al. Hypoxic Preconditioning Induces Changes in HIF-1 Target Genes in Neonatal Rat Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[90] Kazushi Fujimoto,et al. Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin , 1998, The Journal of cell biology.
[91] F. Joó. The blood-brain barrier in vitro: The second decade , 1993, Neurochemistry International.